I Ford
2 Blagrave Street
Reading RG1 1AZ
United Kingdom
44 7490 391888
https://www.provexis.com
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 2
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Ian Ford BA (Hons) ACA, F.C.A. | CEO, CFO, Company Secretary & Executive Director | 174.89k | N/A | 1965 |
Dr. Niamh Ann O'Kennedy B.Sc., BSc, M.Sc., MSc, Ph.D. | Chief Scientific Officer, Member of Scientific Advisory Board & Executive Director | 99.05k | N/A | 1973 |
Prof. Asim K. Duttaroy BS MS Ph.D., DSc FICN | Consultant & Member of Scientific Advisory Board | N/A | N/A | N/A |
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function. The company sells its products through distributors and online channels. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
Provexis plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.